- May 23, 2017 | BY
A report from two recent events that highlight how and why we do Huntington’s research
- May 22, 2017 | BY
SynPharm: An electric ‘vade mecum’ for manipulators of biological signaling
- May 19, 2017 | BY
Why spring smells like it does, are we closer to solving Huntington’s and reprogramming blood stem cells.
- May 18, 2017 | BY
Scientist Alicia Ryberg immerses herself in the culture of Nicaragua and gains a much greater perspective than she ever anticipated. An ongoing series about Charles River sabbaticals.
- May 16, 2017 | BY
In drug discovery for rare diseases, gene therapies are beginning to show clinical promise. Will the strategy pay off? A report from a Charles River symposium
- May 12, 2017 | BY
A potential cure for gluten sensitivities, can tracking a cancer tumor lead to a cure and is artificial sweetener making you chubby?
- May 11, 2017 | BY
After routine chemotherapy loses steam, ovarian cancer survivor Beth Hoover finds a reprieve with targeted therapy and a clinical trial. A Eureka Moments story.
- May 8, 2017 | BY
The creatures we fear are also aiding the development of drugs for diabetes, cancer, neurological disorders and inflammatory diseases.
- May 5, 2017 | BY
Seeing your face in 3D, the science behind losing an eye and can sweat offer up important clues about our health?
- May 3, 2017 | BY
How the gene editing system known as CRISPR-Cas9 is transforming how we create animal models of disease.